Pfizer: Pneumococcal Infections trials

The registry lists 75 Pneumococcal Infections studies with Pfizer as lead sponsor. 4 are open to participants now and 45 have results posted.

Phase 1 10Phase 2 9Phase 3 33Phase 4 7No phase 18(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate 20vPnC in Healthy Chinese InfantsRecruitingNCT07754539Phase 3
• Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and AdolescentsRecruitingNCT07660198Phase 3
• A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.RecruitingNCT07629440Phase 3
• A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy InfantsRecruitingNCT07573462Phase 3
• A Phase 2 Study to Learn About a Monovalent Pneumococcal Conjugate Candidate in Healthy ToddlersCompletedNCT06116591Phase 2Results posted
• A Study to Learn About the Safety and Immune Response of 20vPnC in Adults in India.CompletedNCT05875727Phase 3Results posted
• A Study To Learn About The Effects Of Pneumococcal Vaccine In People With HIVCompletedNCT05794191Results posted
• Safety and Immunogenicity of Pneumococcal Conjugate Formulations in Healthy Adults 18 Through 49 Years of AgeCompletedNCT05489328Phase 1Results posted
• Safety and Immunogenicity of 20vPnC in Toddlers With 2 Prior Doses of Prevenar 13CompletedNCT05408429Phase 3Results posted
• A Study to Describe the Safety of a Vaccine (Called 13vPnC) in Healthy People 18 to 49 Years of Age in IndiaCompletedNCT05329259Phase 4Results posted
• Safety and Immunogenicity Study of 20vPnC When Coadministered With a Booster Dose of BNT162b2CompletedNCT04887948Phase 3Results posted
• 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Pneumococcal Vaccine-Naïve Adults 60 Years of Age and Older in Japan, Korea, and TaiwanCompletedNCT04875533Phase 3Results posted
• Safety and Immunogenicity Study of 20vPnC in Healthy Children 15 Months Through 17 Years of AgeCompletedNCT04642079Phase 3Results posted
• 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 3-Dose Series in Healthy InfantsCompletedNCT04546425Phase 3Results posted
• 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Healthy Japanese InfantsCompletedNCT04530838Phase 3Results posted
• Safety and Immunogenicity of 20vPnC Coadministered With SIIV in Adults ≥65 Years of AgeCompletedNCT04526574Phase 3Results posted
• 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy InfantsCompletedNCT04382326Phase 3Results posted
• 20-valent Pneumococcal Conjugate Vaccine Safety Study in Healthy InfantsCompletedNCT04379713Phase 3Results posted
• Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Vaccine in Adults 65 Years of Age or Older With Prior Pneumococcal VaccinationCompletedNCT03835975Phase 3Results posted
• Trial to Evaluate the Safety and Immunogenicity of 3 Lots of 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naïve AdultsCompletedNCT03828617Phase 3Results posted
• Trial to Evaluate the Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-naïve AdultsCompletedNCT03760146Phase 3Results posted
• A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Infants and Young ChildrenCompletedNCT03574389Phase 3Results posted
• A Safety And Immunogenicity Study Of A 13-valent Pneumococcal Conjugate Vaccine In Japanese Subjects Aged 6 To 64 Years.CompletedNCT03571607Phase 3Results posted
• Study to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine Given With Prevnar 13 in Healthy InfantsTerminatedNCT03550313Phase 2Results posted
• Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine in Healthy InfantsCompletedNCT03512288Phase 2Results posted
• A Trial To Evaluate A Multivalent Pneumococcal Conjugate Vaccine In Healthy Adults 50-85 Years Of AgeCompletedNCT03313050Phase 2Results posted
• Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Adults 60 Through 64 Years of AgeCompletedNCT03313037Phase 2Results posted
• Immunization To Prevent Acute COPD ExacerbationsTerminatedNCT03276754Results posted
• Post Market Surveillance to Observe Safety of Prevenar13™ in AdultsCompletedNCT01834222Results posted
• 13-valent Pneumococcal Conjugate Vaccine Study in Adults => 50 Years of Age in MexicoCompletedNCT01432262Phase 3Results posted
• Safety Surveillance of Pneumococcal 13-valent Conjugate Vaccine Among FilipinosCompletedNCT01396434Results posted
• A Study to Assess the Antibody Response of Healthy Chinese Children Who Have Been Vaccinated Previously With 4-doses of Prevenar (a Pneumococcal Vaccine) as Babies and ToddlersCompletedNCT01298544Phase 4Results posted
• A Study To Assess The Safety And Effectiveness Of Prevenar In Chinese Children Who Have Not Previously Received A Vaccine Against Pneumococcal BacteriaCompletedNCT01193582Phase 4Results posted
• Postlicensure Observational Safety Study of 13vPnC Administered to Infants and ToddlersCompletedNCT01128426Results posted
• Safety & Immunogenicity of 13vPnC in HIV-Infected Subjects Aged 18 or Older Who Were Previously Immunized With 23vPSCompletedNCT00963235Phase 3Results posted
• Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in HIV-Infected Subjects 6 Years of Age or Older Who Are Naive to Pneumococcal VaccineCompletedNCT00962780Phase 3Results posted
• Prevalence of Nasopharyngeal Carriage of Streptococcus Pneumoniae in Healthy Children of 12-18 Months in 6 Cities, ChinaCompletedNCT00952367Results posted
• Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in AdultsCompletedNCT00744263Phase 4Results posted
• Study Evaluating the Impact of the 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Alaskan Native Children.CompletedNCT00743652Phase 3Results posted
• Study Evaluating The Safety, Tolerability And Immunogenicity Of A 13-Valent Pneumococcal Conjugate Vaccine (13vPnC)CompletedNCT00546572Phase 3Results posted
• Study Evaluating the Impact of a 13-valent Pneumococcal Conjugate Vaccine on Nasopharyngeal ColonizationCompletedNCT00508742Phase 3Results posted
• Study Evaluating Safety of 13-Valent Pneumococcal Conjugate Vaccine in Healthy Elderly SubjectsCompletedNCT00500266Phase 3Results posted
• Study Evaluating Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine With Influenza Vaccine in AdultsCompletedNCT00492557Phase 3Results posted
• Study Evaluating 7-Valent Pneumococcal Conjugate Vaccine in Healthy InfantsCompletedNCT00488826Phase 1Results posted
• Nasopharyngeal Streptococcus Pneumoniae CarriageCompletedNCT00471822Results posted
• Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants in IndiaCompletedNCT00452790Phase 3Results posted
• Study Evaluating 13-valent Pneumococcal Conjugate Vaccine Catch-Up Regimens in Older Infants and ChildrenCompletedNCT00452452Phase 3Results posted
• Study Comparing a 13-valent Pneumococcal Conjugate Vaccine With 23-valent Pneumococcal Polysaccharide Vaccine in AdultsCompletedNCT00427895Phase 3Results posted
• Study Evaluating Pneumococcal Vaccine in Healthy InfantsCompletedNCT00205803Phase 1/2Results posted
• A Study to Assess the Safety, Tolerability, and Immunogenicity of 3 Lots of a Multivalent Pneumococcal Conjugate Vaccine Administered to AdultsActive, not recruitingNCT07794748Phase 3
• A Study to Understand the Safety of the 20vPnC Vaccine in Healthy Chinese Adults, Children, and InfantActive, not recruitingNCT07023081Phase 1
• A Study to Learn About How Safe and Effective is 20vPnC and 13vPnC Vaccines in Chinese AdultsCompletedNCT07019909Phase 1
• A Study to Learn About the Safety of PREVENAR 20 Vaccine in Infants Aged Between Two to Six MonthsActive, not recruitingNCT06622109
• A Study to Learn About How a New Pneumococcal Vaccine Works in ChildrenCompletedNCT06531538Phase 2
• A Study to Learn About How a New Pneumococcal Vaccine Works in InfantsActive, not recruitingNCT06524414Phase 2
• A Study to Learn About the Safety and Immune Response of a New Pneumococcal Vaccine in AdultsCompletedNCT06182124Phase 1/2
• A Study to Learn About a Type of Pneumococcal Vaccine With a New Ingredient (PF-07872411) Intended to Enhance the Effects of the Vaccine Which is Given to AdultsCompletedNCT05831124Phase 1
• A Study to Describe the Safety and Immunogenicity of 20vPnC in Infants in India and TaiwanCompletedNCT05512819Phase 3
• Trial to Evaluate the Safety and Immunogenicity of Multivalent Pneumococcal Vaccines in Japanese Adults 18 to 49 Years of AgeCompletedNCT03642847Phase 1
• A Phase 1, Randomized, Controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults Aged 18 to 49 YearsCompletedNCT02955160Phase 1
• Serotype Distribution of Streptococcus Pneumoniae That Causes Invasive Diseases at Children and Adults in TurkeyCompletedNCT01810861
• A Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) In Healthy Infants In ChinaCompletedNCT01692886Phase 3
• Serotype Distribution of Chest X-ray Confirmed Pneumococcal Community Acquired Pneumonia in the Adult Population in Greece, Over 1 Year.CompletedNCT01564771
• A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese SubjectsCompletedNCT01531322Phase 1
• Child Pneumococcal Serotype Epidemiology In GreeceCompletedNCT01111214
• Disease Burden of Pneumonia, Meningitis and Bacteremia Among Children in Japan: Pneumonet JapanCompletedNCT00757575
• Study Evaluating the Safety and Ability to Produce Immune Response of Prevenar and Meningitec Given at the Same TimeCompletedNCT00581035Phase 4
• Safety and Local Tolerability of Prevenar in Indian ChildrenCompletedNCT00488800
• Study Evaluating Streptococcus Pneumoniae Nasopharyngeal Carriage Rate in Children Receiving Prevnar®CompletedNCT00488371
• Pneumoniae Epidemiology Study in ChinaCompletedNCT00471770
• Immunogenicity and Safety Study of Pneumococcal 7-Valent Conjugate Vaccine in Sickle Cell Disease Infants.TerminatedNCT00368186Phase 4
• Study Evaluating Prevenar Vaccine in Healthy InfantsCompletedNCT00276107Phase 4
• Study Evaluating Prevenar in High-Risk ChildrenCompletedNCT00234338
• Study of Streptococcus Pneumoniae in Nose and Throats of Infants With Acute Otitis MediaCompletedNCT00195611
• Study Investigating Administration of Prevenar for Post-Marketing SurveillanceCompletedNCT00195390